ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.00
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      62,999.65
      -1.16%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Alaunos Therapeutics Inc (TCRT)

      7. Alaunos Therapeutics Inc (TCRT) News

      TCRT

      Alaunos Therapeutics (TCRT)

      Alaunos Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TCRT
      DateTimeSourceHeadlineSymbolCompany
      02/28/20249:46PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
      02/22/20244:44PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
      02/20/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
      02/14/202412:43PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRTAlaunos Therapeutics Inc
      02/13/20244:58PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRTAlaunos Therapeutics Inc
      01/29/20248:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
      01/23/20245:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
      01/22/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
      01/03/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
      01/03/20245:25PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
      01/02/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
      12/28/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
      12/22/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
      11/15/20237:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
      11/14/20237:30AMGlobeNewswire Inc.Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
      09/28/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
      09/05/20235:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
      09/01/202312:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
      08/14/20234:37PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRTAlaunos Therapeutics Inc
      08/14/20234:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
      08/14/20234:05PMGlobeNewswire Inc.Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
      06/29/20237:00AMGlobeNewswire Inc.Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic MalignanciesNASDAQ:TCRTAlaunos Therapeutics Inc
      06/12/20234:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRTAlaunos Therapeutics Inc
      06/08/20235:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRTAlaunos Therapeutics Inc
      06/08/20235:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRTAlaunos Therapeutics Inc
      05/25/20235:00PMGlobeNewswire Inc.Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
      05/10/20237:32AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TCRTAlaunos Therapeutics Inc
      05/10/20237:00AMGlobeNewswire Inc.Alaunos Therapeutics Reports First Quarter 2023 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
      05/03/20238:30AMGlobeNewswire Inc.Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023NASDAQ:TCRTAlaunos Therapeutics Inc
      04/26/202312:30PMGlobeNewswire Inc.Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:TCRT